国际口腔医学杂志 ›› 2017, Vol. 44 ›› Issue (4): 459-465.doi: 10.7518/gjkq.2017.04.018
张建康, 卫俊俊, 唐曌隆, 余云波, 敬伟
Zhang Jiankang, Wei Junjun, Tang Zhaolong, Yu Yunbo, Jing Wei
摘要: 社会老龄化的加剧使老年个体骨损伤修复问题愈发突出,骨髓间充质干细胞(BMSC)是一种与骨代谢再生密切相关的骨髓细胞,其生物学特性(形态、表面特征、细胞周期、端粒酶以及细胞内活性氧簇水平等)以及增殖分化能力在生物体年龄影响下均发生了改变,成骨能力下降,影响了骨损伤的修复速度和质量。探索其中分子机制对改善老龄个体骨损伤康复有至关重要作用。参与调控的信号中,Wnt和Notch近年日益受到关注,二者对老龄BMSC成骨的调控有交互作用。老龄机体的氧化应激反应增加而生长因子生成减少,Wnt通路的转录因子β-catenin与叉头家族转录因子的亲和力增加,不再与T细胞因子和淋巴增强因子结合,故BMSC成骨减弱。同时老龄个体骨髓中BMSC数量减少,Notch抑制BMSC成骨来维持祖细胞池中BMSC的数量。Wnt和Notch之间还存在相互作用,如Notch过表达能够削弱Wnt的影响等。此外,BMP-Smad转录因子活性下降,Hedgehog信号通路下调,亦影响着BMSC的成骨分化。本文对老龄个体BMSC生物学性能变化及其成骨分化过程中信号通路的调控作用进行综述,为老龄个体骨相关性疾病的治疗提供新思路。
中图分类号:
[1] Ross CL, Siriwardane M, Almeida-Porada G, et al. The effect of low-frequency electromagnetic field on human bone marrow stem/progenitor cell differentia-tion[J]. Stem Cell Res, 2015, 15(1):96-108. [2] Lynch K, Pei M. Age associated communication between cells and matrix: a potential impact on stem cell-based tissue regeneration strategies[J]. Organo-genesis, 2014, 10(3):289-298. [3] Yu JM, Wu X, Gimble JM, et al. Age-related chan-ges in mesenchymal stem cells derived from rhesus macaque bone marrow[J]. Aging Cell, 2011, 10(1): 66-79. [4] Stolzing A, Jones E, McGonagle D, et al. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies[J]. Mech Ageing Dev, 2008, 129(3):163-173. [5] Dantzer B, Fletcher QE. Telomeres shorten more slowly in slow-aging wild animals than in fast-aging ones[J]. Exp Gerontol, 2015, 71:38-47. [6] Oh J, Lee YD, Wagers AJ. Stem cell aging: mechan-isms, regulators and therapeutic opportunities[J]. Nat Med, 2014, 20(8):870-880. [7] Efimenko AY, Kochegura TN, Akopyan ZA, et al. Autologous stem cell therapy: how aging and chronic diseases affect stem and progenitor cells[J]. Biores Open Access, 2015, 4(1):26-38. [8] Baxter MA, Wynn RF, Jowitt SN, et al. Study of telomere length reveals rapid aging of human mar-row stromal cells following in vitro expansion[J]. Stem Cells, 2004, 22(5):675-682. [9] 付欣. 初步探讨自然衰老小鼠骨髓间充质干细胞生物学行为及β-catenin对其分化功能的影响[D]. 西安: 第四军医大学, 2013. Fu X. Research on the biological function of BMMSCs from natural aging mice and the effects on the dif-ferentiation functions of β-catenin[D]. Xi’an: Fourth Military Medical University, 2013. [10] Xiao JJ, Zhao WJ, Zhang XT, et al. Bergapten promotes bone marrow stromal cell differentiation into osteoblasts in vitro and in vivo [J]. Mol Cell Biochem, 2015, 409(1/2):113-122. [11] Zhang W, Ou G, Hamrick M, et al. Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells[J]. J Bone Miner Res, 2008, 23(7):1118-1128. [12] Leucht P, Jiang J, Cheng D, et al. Wnt3a reestab-lishes osteogenic capacity to bone grafts from aged animals[J]. J Bone Joint Surg Am, 2013, 95(14): 1278-1288. [13] Saito-Diaz K, Chen TW, Wang X, et al. The way Wnt works: components and mechanism[J]. Growth Factors, 2013, 31(1):1-31. [14] Niehrs C. The complex world of WNT receptor signalling[J]. Nat Rev Mol Cell Biol, 2012, 13(12): 767-779. [15] Yu J, Virshup D. Updating the Wnt pathways[J]. Biosci Rep, 2014, 34(5):593-607. [16] Fujimaki S, Wakabayashi T, Takemasa T, et al. The regulation of stem cell aging by Wnt signaling[J]. Histol Histopathol, 2015, 30(12):1411-1430. [17] Acebron SP, Karaulanov E, Berger BS, et al. Mitotic Wnt signaling promotes protein stabilization and re- gulates cell size[J]. Mol Cell, 2014, 54(4):663-674. [18] Vinyoles M, Del Valle-Pérez B, Curto J, et al. Multi-vesicular GSK3 sequestration upon Wnt signaling is controlled by p120-catenin/cadherin interaction with LRP5/6[J]. Mol Cell, 2014, 53(3):444-457. [19] Shahnazari M, Yao W, Corr M, et al. Targeting the Wnt signaling pathway to augment bone formation [J]. Curr Osteoporos Rep, 2008, 6(4):142-148. [20] Milovanovic P, Adamu U, Simon MJ, et al. Age- and sex-specific bone structure patterns portend bone fragility in radii and tibiae in relation to osteodensi-tometry: ahigh-resolution peripheral quantitative computed tomography study in 385 individuals[J]. J Gerontol A Biol Sci Med Sci, 2015, 70(10):1269- 1275. [21] Ng AH, Baht GS, Alman BA, et al. Bone marrow stress decreases osteogenic progenitors[J]. Calcif Tissue Int, 2015, 97(5):476-486. [22] Iyer S, Ambrogini E, Bartell SM, et al. FOXOs attenuate bone formation by suppressing Wnt signa-ling[J]. J Clin Invest, 2013, 123(8):3409-3419. [23] Georgiou KR, Hui SK, Xian CJ. Regulatory path-ways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocor-ticoid therapy and radiotherapy[J]. Am J Stem Cell, 2012(3):205-224. [24] Almeida M, Han L, Martin-Millan M, et al. Oxida-tive stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription[J]. J Biol Chem, 2007, 282(37):27298-27305. [25] Guan H, Tan P, Xie L, et al. FOXO1 inhibits osteo-sarcoma oncogenesis via Wnt/β-catenin pathway suppression[J]. Oncogenesis, 2015, 4(9):e166. [26] Schwanbeck R. The role of epigenetic mechanisms in Notch signaling during development[J]. J Cell Physiol, 2015, 230(5):969-981. [27] Perdigoto CN, Bardin AJ. Sending the right signal: Notch and stem cells[J]. Biochim Biophys Acta, 2013, 1830(2):2307-2322. [28] Ables JL, Decarolis NA, Johnson MA, et al. Notch1 is required for maintenance of the reservoir of adult hippocampal stem cells[J]. J Neurosci, 2010, 30(31): 10484-10492. [29] Watanabe K, Ikeda K. Osteoblast differentiation and bone formation[J]. Nippon Rinsho, 2009, 67(5):879- 886. [30] Hilton MJ, Tu X, Wu X, et al. Notch signaling main-tains bone marrow mesenchymal progenitors by sup-pressing osteoblast differentiation[J]. Nat Med, 2008, 14(3):306-314. [31] Li JL, Harris AL. Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic im-plications[J]. Front Biosci(Landmark Ed), 2009, 14: 3094-3110. [32] Zanotti S, Canalis E. Notch and the skeleton[J]. Mol Cell Biol, 2010, 30(4):886-896. [33] Mead TJ, Yutzey KE. Notch pathway regulation of chondrocyte differentiation and proliferation during appendicular and axial skeleton development[J]. Proc Natl Acad Sci USA, 2009, 106(34):14420-14425. [34] Collu GM, Hidalgo-Sastre A, Brennan K. Wnt-Notch signalling crosstalk in development and disease[J]. Cell Mol Life Sci, 2014, 71(18):3553-3567. [35] Caliceti C, Nigro P, Rizzo P, et al. ROS, Notch, and Wnt signaling pathways: crosstalk between three major regulators of cardiovascular biology[J]. Biomed Res Int, 2014, 2014:318714. [36] Deregowski V, Gazzerro E, Priest L, et al. Notch 1 overexpression inhibits osteoblastogenesis by sup-pressing Wnt/beta-catenin but not bone morphogene-tic protein signaling[J]. J Biol Chem, 2006, 281(10): 6203-6210. [37] Pawłowska E, Wójcik KA, Synowiec E, et al. Ex-pression of RUNX2 and its signaling partners TCF7, FGFR1/2 in cleidocranial dysplasia[J]. Acta Biochim Pol, 2015, 62(1):123-126. [38] Collu GM, Hidalgo-Sastre A, Acar A, et al. Dishe-velled limits Notch signalling through inhibition of CSL[J]. Development, 2012, 139(23):4405-4415. [39] Kazmers NH, McKenzie JA, Shen TS, et al. Hedge-hog signaling mediates woven bone formation and vascularization during stress fracture healing[J]. Bone, 2015, 81:524-532. [40] Yang J, Andre P, Ye L, et al. The Hedgehog signal-ling pathway in bone formation[J]. Int J Oral Sci, 2015, 7(2):73-79. [41] James AW. Review of signaling pathways gover-ning MSC osteogenic and adipogenic differentia-tion[J]. Scientifica, 2013, 2013:1-17. [42] Tang Z, Wang Z, Qing F, et al. Bone morphogenetic protein Smads signaling in mesenchymal stem cells affected by osteoinductive calcium phosphate cera-mics[J]. J Biomed Mater Res A, 2015, 103(3):1001- 1010. [43] Sharma AK, Taneja G, Khanna D, et al. Reactive oxygen species: friend or foe[J]. RSC Adv, 2015, 5 (71):57267-57276. [44] Xie Q, Lan G, Zhou Y, et al. Strategy to enhance the anticancer efficacy of X-ray radiotherapy in me-lanoma cells by platinum complexes, the role of ROS-mediated signaling pathways[J]. Cancer Lett, 2014, 354(1):58-67. [45] 李丽莉. BMP-Smad信号通路的调节及其在成骨分化中的作用[D]. 济南: 山东大学, 2013. Li LL. Regulation of BMP-Smad signaling and its function in osteogenic differentiation[D]. Jinan: Shandong University, 2013. [46] Cai JQ, Huang YZ, Chen XH, et al. Sonic Hedgehog enhances the proliferation and osteogenic differentia-tion of bone marrow-derived mesenchymal stem cells[J]. Cell Biol Int, 2012, 36(4):349-355. [47] Regard JB, Malhotra D, Gvozdenovic-Jeremic J, et al. Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification[J]. Nat Med, 2013, 19(11):1505-1512. [48] Kim WK, Meliton V, Bourquard N, et al. Hedgehog signaling and osteogenic differentiation in multi-potent bone marrow stromal cells are inhibited by oxidative stress[J]. J Cell Biochem, 2010, 111(5): 1199-1209. |
[1] | 古丽其合热·阿布来提,秦旭,朱光勋. 线粒体自噬在牙周炎发生发展过程中的研究进展[J]. 国际口腔医学杂志, 2024, 51(1): 68-73. |
[2] | 蒋青松,赖文莉,王艳. 骨增量技术在口腔正畸领域的研究进展[J]. 国际口腔医学杂志, 2023, 50(2): 243-250. |
[3] | 刘体倩,梁星,刘蔚晴,李晓虹,朱睿. 咬合创伤在牙周炎发生发展中的作用及机制的研究进展[J]. 国际口腔医学杂志, 2023, 50(1): 19-24. |
[4] | 张静怡,李丹薇,孙宇,雷雅燕,刘涛,龚瑜. 复合树脂及复合体对成骨细胞毒性及成骨向分化的影响[J]. 国际口腔医学杂志, 2022, 49(4): 412-419. |
[5] | 洪娅娅,陈学鹏,姒蜜思. 非编码RNA调控牙囊干细胞成骨分化的研究进展[J]. 国际口腔医学杂志, 2022, 49(3): 263-271. |
[6] | 郭雨婷,吕学超. 药物调控牙髓干细胞成骨分化的研究进展[J]. 国际口腔医学杂志, 2021, 48(6): 737-744. |
[7] | 刘娟,陈斌,闫福华. 富血小板血浆和浓缩生长因子对人牙周膜细胞增殖和成骨分化影响的研究[J]. 国际口腔医学杂志, 2021, 48(5): 520-527. |
[8] | 钱颖,龚佳幸,俞梦飞,刘宇,魏栋,朱子羽,陆科杰,王慧明. 从分子生物学角度对成釉细胞瘤诊断及治疗的考量[J]. 国际口腔医学杂志, 2021, 48(5): 570-578. |
[9] | 周梦琪,陈学鹏,傅柏平. 正畸治疗中牙槽骨骨开窗骨开裂的预防和应对策略[J]. 国际口腔医学杂志, 2021, 48(5): 600-608. |
[10] | 陈野, 周丰, 邬琼辉, 车会凌, 李佳璇, 申佳琪, 罗恩. 脂联素对骨髓间充质干细胞的作用及其调控机制[J]. 国际口腔医学杂志, 2021, 48(1): 58-63. |
[11] | 李佩仪,张新春. 微环境酸碱度在组织工程骨再生中作用的研究进展[J]. 国际口腔医学杂志, 2021, 48(1): 64-70. |
[12] | 李静雅,税钰森,郭永文. 循环牵张应力影响人牙周膜细胞成骨分化机制的研究进展[J]. 国际口腔医学杂志, 2020, 47(6): 652-660. |
[13] | 吕辉,王华,孙雯. 辅助性T细胞17与牙周炎骨免疫[J]. 国际口腔医学杂志, 2020, 47(6): 661-668. |
[14] | 孙坚炜,雷利红,谭静怡,陈莉丽. 微小RNA 155对骨免疫的调控及其在牙周炎中作用的研究进展[J]. 国际口腔医学杂志, 2020, 47(5): 607-615. |
[15] | 王欢,刘洋,戚孟春,李静怡,刘梦楠,孙红. 微弧氧化技术制备钛基种植体表面涂层的研究进展[J]. 国际口腔医学杂志, 2020, 47(4): 439-444. |
|